Efficacy and safety of mogamulizumab by patient baseline blood tumour burden: a post hoc analysis of the MAVORIC trial
暂无分享,去创建一个
J. Scarisbrick | P. Zinzani | L. Iversen | P. Quaglino | L. Sokol | J. Rosen | R. Dummer | L. Pinter-Brown | A. Musiek | R. Cowan | J. Nicolay | F. Foss | T. Ito | M. Medley